The prevalence of anti-HCV antibody in risk groups and blood donors.
Anti-HCV antibody was detected in 1.9% of the blood donors in University Hospital. Among the risk groups, 33.3% of the patients with post-transfusion hepatitis were tested positive for anti-HCV antibody. The anti-HCV antibody was detected in 30% of the IDU. Haemodialysis patients, patients with acute and chronic hepatitis and patients with liver cirrhosis appeared to have increased risk of Hepatitis C virus infection. The results indicate that the frequency of HCV infection increases with the exposure to blood or blood products.
Ng
K P
KP
Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala, Lumpur.
Saw
T L
TL
Wong
N W
NW
Goh
K L
KL
Chuah
S Y
SY
Nagaratnam
M
M
D001782:Blood Donors; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D015995:Prevalence; D006435:Renal Dialysis / Q000009:adverse effects; D015819:Substance Abuse, Intravenous / Q000150:complications; D065227:Transfusion Reaction
D018937:Hepatitis C Antibodies